News & Updates

Extended anticoagulation benefits cancer patients with distal DVT
Extended anticoagulation benefits cancer patients with distal DVT
20 Sep 2023 byAudrey Abella

In cancer patients with isolated distal deep vein thrombosis (IDDVT), a 12-month anticoagulation regimen with the oral factor Xa inhibitor edoxaban fared better than a 3-month regimen, findings from the ONCO DVT study have shown.

Extended anticoagulation benefits cancer patients with distal DVT
20 Sep 2023
Study confirms causal link between plasma cortisol and hypertension
Study confirms causal link between plasma cortisol and hypertension
18 Sep 2023